Ephrin Receptor
Ephrin Receptor(Ephrin受体)
Ephrin receptors (Ephs) are a group of receptors that are activated in response to binding ephrin. Ephs form the largest known subfamily of receptor tyrosine kinases (RTKs). Both Ephs and their corresponding ephrin ligands are membrane-bound proteins that require direct cell-cell interactions for Eph receptor activation. Eph/ephrin signaling has been implicated in the regulation of a host of processes critical to embryonic development including axon guidance, formation of tissue boundaries, cell migration, and segmentation. Additionally, Eph/epherin signaling has recently been identified to play a critical role in the maintenance of several processes during adulthood including long-term potentiation, angiogenesis, and stem cell differentiation and cancer. The ability of Ephs and ephrins to mediate a variety of cell-cell interactions places the Eph/ephrin system in an ideal position to regulate a variety of different biological processes during embryonic development.
Ephrin Receptor 相关产品(13)
- GC11134ALW-II-41-27CAS: 1186206-79-0纯度: >99.50% / >98.00%
ALW-II-41-27 是一种 Eph 家族酪氨酸激酶抑制剂,抑制 Eph2 的 IC50 为 11 nM。
- GC25367Ehp-inhibitor-1CAS: 861249-59-4
Ehp-inhibitor-1 (Ehp inhibitor 2) is an Eph family tyrosine kinase inhibitor that targets Eph receptors.
- GC36782NVP-BHG712 isomerCAS: 2245892-85-5纯度: >99.00%
NVP-BHG712 isomer,是NVP-BHG712 的位置异构体,与EPHA2和EPHB4显示保守非键结合。
- GC69258IfabotuzumabCAS: 2147698-66-4纯度: >95.00%
Ifabotuzumab (KB004) 是靶向 EphA3 的 IgG1κ 抗体 (KD=610 pM)。Ifabotuzumab 能够导致肿瘤细胞凋亡,并激活抗体依赖性细胞介导的细胞毒作用 (ADCC),破坏肿瘤脉管系统。Ifabotuzumab 能够减少人特发性肺纤维化 (IPF) CCR10+ 细胞,改善肺纤维化。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC11134 | ALW-II-41-27 | 1186206-79-0 | >99.50% / >98.00% | |
ALW-II-41-27 是一种 Eph 家族酪氨酸激酶抑制剂,抑制 Eph2 的 IC50 为 11 nM。 | ||||
| GC14332 | NVP-BHG712 | 940310-85-0 | >99.50% | |
A selective EphB4 kinase inhibitor | ||||
| GC18168 | JI-101 | 900573-88-8 | >99.00% | |
An inhibitor of VEGFR2, PDGFRβ, and EphB4 | ||||
| GC25367 | Ehp-inhibitor-1 | 861249-59-4 | - | |
Ehp-inhibitor-1 (Ehp inhibitor 2) is an Eph family tyrosine kinase inhibitor that targets Eph receptors. | ||||
| GC31752 | Tesevatinib (XL-647) | 781613-23-8 | >98.00% | |
A multi-kinase inhibitor | ||||
| GC35053 | 123C4 | 2034159-30-1 | - | |
123C4 是一种有效、选择性的,竞争性受体酪氨酸激酶 EPHA4 激动剂,Ki 值为 0.65 μM. | ||||
| GC36782 | NVP-BHG712 isomer | 2245892-85-5 | >99.00% | |
NVP-BHG712 isomer,是NVP-BHG712 的位置异构体,与EPHA2和EPHB4显示保守非键结合。 | ||||
| GC50137 | KYL | 676657-00-4 | - | |
An EphA4 inhibitor | ||||
| GC64856 | UniPR129 | 1639159-47-9 | >99.00% | |
UniPR129 是一种有效 Eph/ephrin 拮抗剂。UniPR129 具有研究癌症疾病的潜力。 | ||||
| GC68647 | ALW-II-49-7 | 1135219-23-6 | >98.00% | |
ALW-II-49-7是一种选择性的EphB2激酶抑制剂,其IC 50 值为40nM。 | ||||
| GC69258 | Ifabotuzumab | 2147698-66-4 | >95.00% | |
Ifabotuzumab (KB004) 是靶向 EphA3 的 IgG1κ 抗体 (KD=610 pM)。Ifabotuzumab 能够导致肿瘤细胞凋亡,并激活抗体依赖性细胞介导的细胞毒作用 (ADCC),破坏肿瘤脉管系统。Ifabotuzumab 能够减少人特发性肺纤维化 (IPF) CCR10+ 细胞,改善肺纤维化。 | ||||
| GC70097 | Urolithin D | 131086-98-1 | >98.00% | |
Urolithin D 是 EphA 受体 的竞争性可逆拮抗剂。Urolithin D 表现出类内选择性。 | ||||
| GC74367 | Targefrin | 3031514-44-7 | >99.00% | |
Targefrin是一种有效的epha2靶向剂,作为拮抗剂。 | ||||
